Skip to main content

Table 2 The incidence of AEs in the included studies

From: Indirect-comparison meta-analysis of treatment options for patients with refractory Kawasaki disease

  Infliximab group (%)   IVMP group (%)
Variable Burns Youn Tremoulet Son Masaaki Miura05 Miura08 Teraguchi Sundel Newburger
Transient hepatomegaly 41.7 19  
Chills 0   6
Rash 10 1 12.5
Headache 2   5
Hemolytic anemia 2   1
Seizure 0  
Hepatitis 0  
Hypertension 0   90 86 6
Coagulopathy 0   27
Bradycardia   82 86
Hypothermia   1 14
Hypotension   5
Hyperglycemia   55 71
Embolism   0 0
Stool blood   0 0 7
Vomiting 6.3 0
Heart failure   0 0
Shock   1